期刊文献+

血清脑钠肽与慢性肾脏病患者舒张性心功能不全的相关性

下载PDF
导出
摘要 目的探讨合并舒张性心功能不全(DHF)的慢性肾脏病(CKD)非透析患者血清脑钠肽(BNP)浓度水平变化及其临床意义。方法 96例经超声心动图检测左室射血分数(LVEF)正常(LVEF≥50%)的CKD非透析患者(K/DOQI分期3~4期),按二尖瓣舒张期E峰与A峰流速比值(E/A)分为心功能正常组(E/A≥1)27例,DHF 1级组(0.8≤E/A<1)24例,DHF 2级组(0.6≤E/A<0.8)27例及DHF 3级组(E/A<0.6)18例,ELISA法检测各组血清BNP浓度水平,并与60例心功能及肾功能正常的对照组做比较。结果与对照组相比,CKD患者各组BNP浓度均增高(P<0.01);与心功能正常组相比,DHF各级组BNP浓度均增高(均P<0.01);且随着舒张性心功能恶化,BNP水平呈逐渐上升趋势;相关分析显示BNP浓度与E/A值呈负相关(r=-0.603,P<0.01)。结论 BNP浓度水平与CKD非透析患者DHF相关,临床测定BNP水平并结合超声心动图有助于对此类患者DHF的综合评估。
出处 《齐齐哈尔医学院学报》 2012年第20期2774-2775,共2页 Journal of Qiqihar Medical University
  • 相关文献

参考文献7

  • 1Vasan RS, Levy D. Defining diastolic heart failure: A call forstandardized diagnostic criteria[J]. Circulation, 2000, 101 (17) :2 118-2 121.
  • 2Fagugll RM, Palumbo B, Rieeardi D, et al. Association be- tween brain natriuretic peptide and extracellular water in hemo- dialysis patients [J]. Nephron Clin Pract,2003,95(2):c60-66.
  • 3许兆延,谭虹,杨希立,李健,张健瑜,蔡炜标.男性心力衰竭患者心功能、血清睾酮与脑钠肽关系探讨[J].实用医学杂志,2010,26(16):2951-2953. 被引量:4
  • 4Jenny AD, Paul PG, Eva P, et al. A Systematic Review of the Diagnostic Accuracy of Natriuretic Peptides for Heart Failure [J]. Arch Intern Med,2004,164(18) :1978-1984.
  • 5Angeja BG, Grossman W. Evaluation and management of dias- tolic heart failure [J]. Circulation, 2003,107 (5) : 659- 663.
  • 6周文彦,倪兆慧,方炜,顾乐怡,王琴,牟姗,曹励欧,俞赞喆,钱家麒.慢性肾脏病非透析患者脑钠素与动脉粥样硬化及心功能的关系[J].中华肾脏病杂志,2007,23(3):162-166. 被引量:21
  • 7Yoshimura M, Yasue H, Ogawa H. Pathophysiolog ical signi- ficance and clinical application of ANP and BNP in patients with heart failure[J]. ? Can J Physiol Pharmaacol, 2001,79 (6) : 730.

二级参考文献21

  • 1金烈,韦铁民,曾春来.血液透析前后血浆B型钠尿肽的变化及对心力衰竭的诊断价值[J].中华肾脏病杂志,2005,21(3):160-160. 被引量:4
  • 2富路,韩颖,李元十,朱立群,戴颖楠,高倩萍,曹君娴,马丹.男性慢性心力衰竭患者血清睾酮、雌二醇水平与心功能的相关性[J].中华心血管病杂志,2006,34(12):1108-1110. 被引量:18
  • 3Miller W L, Hartman K A, Grill D E, et al. Only large reductions in concentrations of natriuretic peptides (BNP and NT- proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure [J]. Clin Chem, 2009, 55 ( 1 ) :78-84.
  • 4Turhan S, Tulunay C, Gillec S. The association between androgen levels and premature coronary artery disease in men [J]. Coron Artery Dis, 2007, 18(3) : 159-162.
  • 5Akiba T, Tachib ana K, Togashi K, et al. Plasma human brain natriuretic peptide in chronic renal failure. Clin Nephrol, 1995, 44 Suppl 1:S61-S64.
  • 6Safley DM, Awad A, Sullivan RA, et al. Changes in B-type natriuretic peptide levels in hemodialysis and the effect of depressed left ventricular function. Adv Chronic Kidney Dis,2005, 12:117-124.
  • 7Foley RN, Parfrey PS, Samak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998, 32 (5 Suppl 3):Sl12-Sl19.
  • 8Levin A, Djurdjev O,Barrett B, et al. Cardiovascular disease in patients with chronic kidney disease:geting to the heart of the matter. Am J Kidney Dis, 2001, 38:1398-1407.
  • 9Mallamaci F, Zoccali C, Tripepi G, et al. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int, 2001, 59:1559-1566.
  • 10Cataliotti A, Malatino LS, Jougasaki M, et al. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natfiuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc, 2001,76:1111-1119.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部